Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07536373) titled 'Colchicine in Chronic Limb-Threatening Ischemia' on April 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Shin Kong Wu Ho-Su Memorial Hospital
Condition:
Chronic Limb-Threatening Ischemia
Intervention:
Drug: Colchicine 0.5 MG Oral Tablet Once Daily
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: April 15, 2026
Target Sample Size: 200
Countries of Recruitment:
Taiwan
To know more, visit ht...